This report aims to provide a comprehensive presentation of the global market for in Vitro Diagnostics (ivd), with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding in Vitro Diagnostics (ivd).
The in Vitro Diagnostics (ivd) market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global in Vitro Diagnostics (ivd) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the in Vitro Diagnostics (ivd) manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
The global in Vitro Diagnostics (ivd) market size in 2022 is 112640.00 million US dollars, and it is expected to be 151245.62 million US dollars by 2029, with a compound annual growth rate of 4.30% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the in Vitro Diagnostics (ivd) market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott (US), and Thermo Fisher Scientific (US). The share of the top 3 players in the in Vitro Diagnostics (ivd) market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, in which North America accounted for XX%, Europe accounted for XX% of in Vitro Diagnostics (ivd) market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Reagents & Kits accounted for XX% of in Vitro Diagnostics (ivd) market in 2022. Instruments share of XX%.
Immunoassay/ Immunochemistry accounted for XX% of the in Vitro Diagnostics (ivd) market in 2022. Clinical Chemistry accounts for XX%.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analyzes the main companies in the in Vitro Diagnostics (ivd) industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 3: Analysis of the competitive environment of in Vitro Diagnostics (ivd) market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and new entrants and expansion plans.
Chapters 4-6: Segmented the global in Vitro Diagnostics (ivd) market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-11: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa in Vitro Diagnostics (ivd) market type, application, country and player market segmentation data, and include SWOT Analysis.
Chapter 12: Analyzes the in Vitro Diagnostics (ivd) business cost, including industrial chain and the proportion of business cost structure.
Chapter 13: The main points and conclusions of the report.
Chapter 14: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
South America
Brazil
Argentina
MEA
Saudi Arabia
Egypt
Turkey
UAE
South Africa
Player list
Roche Diagnostics (Switzerland)
Siemens Healthineers (Germany)
Danaher Corporation (US)
Abbott (US)
Thermo Fisher Scientific (US)
Johnson & Johnson (US)
Becton Dickinson & Company (US)
Bio-Rad Laboratories (US)
Sysmex Corporation (Japan)
bioMérieux (France)
DiaSorin (Italy)
Ortho Clinical Diagnostics (US)
QIAGEN N.V. (Netherlands)
Types list
Reagents & Kits
Instruments
Services
Data Management Software
Application list
Immunoassay/ Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Hematology
Microbiology
Coagulation & Hemostasis
Urinalysis
Other Technologies
Table of Content
1 Market Overview
1.1 in Vitro Diagnostics (ivd) Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global in Vitro Diagnostics (ivd) Market Size & Forecast
1.4.1 Global in Vitro Diagnostics (ivd) Revenue (2018 VS 2022 VS 2029)
1.4.2 Global in Vitro Diagnostics (ivd) Revenue in Value (2018-2029)
1.5 Market Drivers, Restraints and Trends
1.5.1 in Vitro Diagnostics (ivd) Market Drivers
1.5.2 in Vitro Diagnostics (ivd) Market Restraints
1.5.3 in Vitro Diagnostics (ivd) Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Roche Diagnostics (Switzerland)
2.1.1 Business Overview
2.1.2 Roche Diagnostics (Switzerland) SWOT Analysis
2.1.3 Roche Diagnostics (Switzerland) in Vitro Diagnostics (ivd) Products and Service Offered
2.1.4 Roche Diagnostics (Switzerland) in Vitro Diagnostics (ivd) Revenue and Gross Margin
2.2 Siemens Healthineers (Germany)
2.2.1 Business Overview
2.2.2 Siemens Healthineers (Germany) SWOT Analysis
2.2.3 Siemens Healthineers (Germany) in Vitro Diagnostics (ivd) Products and Service Offered
2.2.4 Siemens Healthineers (Germany) in Vitro Diagnostics (ivd) Revenue and Gross Margin
2.3 Danaher Corporation (US)
2.3.1 Business Overview
2.3.2 Danaher Corporation (US) SWOT Analysis
2.3.3 Danaher Corporation (US) in Vitro Diagnostics (ivd) Products and Service Offered
2.3.4 Danaher Corporation (US) in Vitro Diagnostics (ivd) Revenue and Gross Margin
2.4 Abbott (US)
2.4.1 Business Overview
2.4.2 Abbott (US) SWOT Analysis
2.4.3 Abbott (US) in Vitro Diagnostics (ivd) Products and Service Offered
2.4.4 Abbott (US) in Vitro Diagnostics (ivd) Revenue and Gross Margin
2.5 Thermo Fisher Scientific (US)
2.5.1 Business Overview
2.5.2 Thermo Fisher Scientific (US) SWOT Analysis
2.5.3 Thermo Fisher Scientific (US) in Vitro Diagnostics (ivd) Products and Service Offered
2.5.4 Thermo Fisher Scientific (US) in Vitro Diagnostics (ivd) Revenue and Gross Margin
2.6 Johnson & Johnson (US)
2.6.1 Business Overview
2.6.2 Johnson & Johnson (US) SWOT Analysis
2.6.3 Johnson & Johnson (US) in Vitro Diagnostics (ivd) Products and Service Offered
2.6.4 Johnson & Johnson (US) in Vitro Diagnostics (ivd) Revenue and Gross Margin
2.7 Becton Dickinson & Company (US)
2.7.1 Business Overview
2.7.2 Becton Dickinson & Company (US) SWOT Analysis
2.7.3 Becton Dickinson & Company (US) in Vitro Diagnostics (ivd) Products and Service Offered
2.7.4 Becton Dickinson & Company (US) in Vitro Diagnostics (ivd) Revenue and Gross Margin
2.8 Bio-Rad Laboratories (US)
2.8.1 Business Overview
2.8.2 Bio-Rad Laboratories (US) SWOT Analysis
2.8.3 Bio-Rad Laboratories (US) in Vitro Diagnostics (ivd) Products and Service Offered
2.8.4 Bio-Rad Laboratories (US) in Vitro Diagnostics (ivd) Revenue and Gross Margin
2.9 Sysmex Corporation (Japan)
2.9.1 Business Overview
2.9.2 Sysmex Corporation (Japan) SWOT Analysis
2.9.3 Sysmex Corporation (Japan) in Vitro Diagnostics (ivd) Products and Service Offered
2.9.4 Sysmex Corporation (Japan) in Vitro Diagnostics (ivd) Revenue and Gross Margin
2.10 bioMérieux (France)
2.10.1 Business Overview
2.10.2 bioMérieux (France) SWOT Analysis
2.10.3 bioMérieux (France) in Vitro Diagnostics (ivd) Products and Service Offered
2.10.4 bioMérieux (France) in Vitro Diagnostics (ivd) Revenue and Gross Margin
2.11 DiaSorin (Italy)
2.11.1 Business Overview
2.11.2 DiaSorin (Italy) SWOT Analysis
2.11.3 DiaSorin (Italy) in Vitro Diagnostics (ivd) Products and Service Offered
2.11.4 DiaSorin (Italy) in Vitro Diagnostics (ivd) Revenue and Gross Margin
2.12 Ortho Clinical Diagnostics (US)
2.12.1 Business Overview
2.12.2 Ortho Clinical Diagnostics (US) SWOT Analysis
2.12.3 Ortho Clinical Diagnostics (US) in Vitro Diagnostics (ivd) Products and Service Offered
2.12.4 Ortho Clinical Diagnostics (US) in Vitro Diagnostics (ivd) Revenue and Gross Margin
2.13 QIAGEN N.V. (Netherlands)
2.13.1 Business Overview
2.13.2 QIAGEN N.V. (Netherlands) SWOT Analysis
2.13.3 QIAGEN N.V. (Netherlands) in Vitro Diagnostics (ivd) Products and Service Offered
2.13.4 QIAGEN N.V. (Netherlands) in Vitro Diagnostics (ivd) Revenue and Gross Margin
3 Global in Vitro Diagnostics (ivd) Market Competition, by Manufacturer
3.1 Global in Vitro Diagnostics (ivd) Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 in Vitro Diagnostics (ivd) Players Market Share in 2022
3.2.2 Top 6 in Vitro Diagnostics (ivd) Players Market Share in 2022
3.2.3 Market Competition Trend
3.3 in Vitro Diagnostics (ivd) Players Head Office, Business Provided
3.4 in Vitro Diagnostics (ivd) Mergers & Acquisitions
3.5 in Vitro Diagnostics (ivd) New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global in Vitro Diagnostics (ivd) Revenue in Value by Type (2018-2029)
4.2 Global in Vitro Diagnostics (ivd) Revenue Share by Type (2018-2029)
5 Market Segment by Application
5.1 Global in Vitro Diagnostics (ivd) Revenue by Application (2018-2029)
5.2 Global in Vitro Diagnostics (ivd) Revenue Share by Application (2018-2029)
6 Global in Vitro Diagnostics (ivd) Market Analysis by Regions
6.1 Global in Vitro Diagnostics (ivd) Revenue and Market Share by Regions
6.1.1 Global in Vitro Diagnostics (ivd) Revenue by Regions (2018-2029)
6.1.2 Global in Vitro Diagnostics (ivd) Revenue Market Share by Regions (2018-2029)
6.2 North America in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
6.3 Europe in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
6.4 Asia Pacific in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
6.5 South America in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
6.6 Middle East and Africa in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
7 North America in Vitro Diagnostics (ivd) by Country, by Type, and by Application
7.1 North America in Vitro Diagnostics (ivd) Revenue by Type (2018-2029)
7.2 North America in Vitro Diagnostics (ivd) Revenue by Application (2018-2029)
7.3 North America in Vitro Diagnostics (ivd) Revenue and Market Share by Countries
7.3.1 North America in Vitro Diagnostics (ivd) Revenue in Value by Country (2018-2029)
7.3.2 United States in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
7.3.3 Canada in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
7.3.4 Mexico in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
7.4 North America SWOT Analysis
8 Europe in Vitro Diagnostics (ivd) by Country, by Type, and by Application
8.1 Europe in Vitro Diagnostics (ivd) Revenue by Type (2018-2029)
8.2 Europe in Vitro Diagnostics (ivd) Revenue by Application (2018-2029)
8.3 Europe in Vitro Diagnostics (ivd) Revenue and Market Share by Countries
8.3.1 Europe in Vitro Diagnostics (ivd) Revenue in Value by Country (2018-2029)
8.3.2 Germany in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
8.3.3 France in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
8.3.4 United Kingdom in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
8.3.5 Russia in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
8.3.6 Italy in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
8.3.7 Nordic in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
8.4 Europe SWOT Analysis
9 Asia Pacific in Vitro Diagnostics (ivd) by Country, by Type, and by Application
9.1 Asia Pacific in Vitro Diagnostics (ivd) Revenue by Type (2018-2029)
9.2 Asia Pacific in Vitro Diagnostics (ivd) Revenue by Application (2018-2029)
9.3 Asia Pacific in Vitro Diagnostics (ivd) Revenue and Market Share by Countries
9.3.1 Asia Pacific in Vitro Diagnostics (ivd) Revenue in Value by Country (2018-2029)
9.3.2 China in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
9.3.3 Japan in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
9.3.4 Korea in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
9.3.5 India in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
9.3.6 Southeast Asia in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
9.3.7 Australia in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
9.4 Asia Pacific SWOT Analysis
10 South America in Vitro Diagnostics (ivd) by Country, by Type, and by Application
10.1 South America in Vitro Diagnostics (ivd) Revenue by Type (2018-2029)
10.2 South America in Vitro Diagnostics (ivd) Revenue by Application (2018-2029)
10.3 South America in Vitro Diagnostics (ivd) Revenue and Market Share by Countries
10.3.1 South America in Vitro Diagnostics (ivd) Revenue in Value by Country (2018-2029)
10.3.2 Brazil in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
10.3.3 Argentina in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
10.4 South America SWOT Analysis
11 Middle East & Africa in Vitro Diagnostics (ivd) by Country, by Type, and by Application
11.1 Middle East & Africa in Vitro Diagnostics (ivd) Revenue by Type (2018-2029)
11.2 Middle East & Africa in Vitro Diagnostics (ivd) Revenue by Application (2018-2029)
11.3 Middle East & Africa in Vitro Diagnostics (ivd) Revenue and Market Share by Countries
11.3.1 Middle East & Africa in Vitro Diagnostics (ivd) Revenue in Value by Country (2018-2029)
11.3.2 Turkey in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
11.3.3 Egypt in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
11.3.4 Saudi Arabia in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
11.3.5 UAE in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
11.3.6 South Africa in Vitro Diagnostics (ivd) Revenue and Growth (2018-2029)
11.4 Middle East and Africa SWOT Analysis
12 in Vitro Diagnostics (ivd) Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 in Vitro Diagnostics (ivd) Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer